Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases

5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases

US Patent 8710261 · Granted Apr 29, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrocyclic compounds as sting agonists and methods and uses thereof2025
Pharmaceutical combination of PRMT5 inhibitors2025
Substituted tricyclic compounds2025
PRMT5 inhibitors2025
Ovotransferrin treatment for the reproductive tract2024
Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors2024
Determining LVEF using electrocardiographic signals2022
Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors2022
Ovotransferrin treatment for the reproductive tract2021
N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives2020
Hydroxyalkyl thiadiazole derivatives2019
Oxazoline and isoxazoline derivatives as CRAC modulators2019